Compounds for targeted degradation of BRD9
US12049464B2 · kind B2 · utility
0Cited by
21References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 2022 |
| Grant date | Jul 30, 2024 |
| Priority date | — |
| Expiry date | Sep 1, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
BRD9 protein degradation compounds or pharmaceutically acceptable salts thereof are provided for the treatment of disorders mediated by BRD9, including but not limited to abnormal cellular proliferation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.